| __timestamp | Geron Corporation | PTC Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 20707000 | 79838000 |
| Thursday, January 1, 2015 | 17831000 | 121816000 |
| Friday, January 1, 2016 | 18047000 | 117633000 |
| Sunday, January 1, 2017 | 11033000 | 117456000 |
| Monday, January 1, 2018 | 13432000 | 171984000 |
| Tuesday, January 1, 2019 | 52072000 | 257452000 |
| Wednesday, January 1, 2020 | 51488000 | 477643000 |
| Friday, January 1, 2021 | 85727000 | 540684000 |
| Saturday, January 1, 2022 | 95518000 | 651496000 |
| Sunday, January 1, 2023 | 125046000 | 666563000 |
Unleashing insights
In the competitive world of biotechnology, innovation is the lifeblood of success. Over the past decade, PTC Therapeutics, Inc. and Geron Corporation have demonstrated contrasting approaches to research and development (R&D) spending. From 2014 to 2023, PTC Therapeutics consistently outpaced Geron Corporation, with R&D expenses growing by over 730%, peaking in 2023. In contrast, Geron Corporation's R&D spending increased by approximately 500% during the same period. This disparity highlights PTC Therapeutics' aggressive investment strategy, which may be a key driver of its innovative pipeline. As the biotech industry continues to evolve, these spending patterns could significantly influence each company's future breakthroughs and market positioning. The data underscores the importance of strategic R&D investment in maintaining a competitive edge in the rapidly advancing field of biotechnology.
GSK plc vs PTC Therapeutics, Inc.: Strategic Focus on R&D Spending
Biogen Inc. vs Geron Corporation: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Bio-Techne Corporation and PTC Therapeutics, Inc.
R&D Insights: How Sarepta Therapeutics, Inc. and PTC Therapeutics, Inc. Allocate Funds
Research and Development Investment: Halozyme Therapeutics, Inc. vs PTC Therapeutics, Inc.
Research and Development Expenses Breakdown: Amneal Pharmaceuticals, Inc. vs Geron Corporation
R&D Insights: How Apellis Pharmaceuticals, Inc. and PTC Therapeutics, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for PTC Therapeutics, Inc. and Perrigo Company plc
Revenue Showdown: PTC Therapeutics, Inc. vs Geron Corporation
Xenon Pharmaceuticals Inc. or Geron Corporation: Who Invests More in Innovation?
Research and Development Investment: Soleno Therapeutics, Inc. vs Geron Corporation
Comparing Innovation Spending: Geron Corporation and Viridian Therapeutics, Inc.